Viewing StudyNCT05705271



Ignite Creation Date: 2024-05-06 @ 6:34 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05705271
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-12
First Post: 2023-01-20

Brief Title: A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys Ability to Work Properly Chronic Kidney Disease Together With Type 2 Diabetes Mellitus
Sponsor:
Organization: Bayer

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 200
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE4
Observational Models:
Time Perspective List:
Who Masked List: